Caroline Alfieri

2.6k total citations · 1 hit paper
38 papers, 2.0k citations indexed

About

Caroline Alfieri is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Caroline Alfieri has authored 38 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 16 papers in Epidemiology and 13 papers in Infectious Diseases. Recurrent topics in Caroline Alfieri's work include Viral-associated cancers and disorders (28 papers), Parvovirus B19 Infection Studies (12 papers) and Lymphoma Diagnosis and Treatment (11 papers). Caroline Alfieri is often cited by papers focused on Viral-associated cancers and disorders (28 papers), Parvovirus B19 Infection Studies (12 papers) and Lymphoma Diagnosis and Treatment (11 papers). Caroline Alfieri collaborates with scholars based in Canada, United States and France. Caroline Alfieri's co-authors include Jerome E. Tanner, Elliott Kieff, Mark Birkenbach, Kathleen Hennessy, Jerome Ritz, KS Anderson, Ralph Shapiro, Carl O’Hara, Alan B. Rickinson and Lawrence S. Young and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Caroline Alfieri

38 papers receiving 2.0k citations

Hit Papers

Expression of Epstein–Barr Virus Transformation–Associate... 1989 2026 2001 2013 1989 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Alfieri Canada 21 1.5k 675 639 585 493 38 2.0k
T B Sculley Australia 26 1.8k 1.2× 878 1.3× 776 1.2× 564 1.0× 937 1.9× 53 2.3k
Rosemary J. Tierney United Kingdom 20 1.2k 0.8× 647 1.0× 441 0.7× 292 0.5× 465 0.9× 26 1.5k
Claire Shannon‐Lowe United Kingdom 27 1.7k 1.1× 791 1.2× 696 1.1× 272 0.5× 830 1.7× 36 2.3k
Heather M. Long United Kingdom 24 1.2k 0.8× 553 0.8× 596 0.9× 270 0.5× 902 1.8× 37 1.8k
Jianmin Zuo United Kingdom 25 1.1k 0.7× 288 0.4× 749 1.2× 361 0.6× 972 2.0× 69 2.0k
Seiji Maruo Japan 26 1.2k 0.8× 491 0.7× 471 0.7× 206 0.4× 1.1k 2.1× 34 2.1k
María Victoria Preciado Argentina 24 1.4k 0.9× 1.0k 1.5× 577 0.9× 235 0.4× 330 0.7× 92 2.0k
I. Gorin France 17 745 0.5× 267 0.4× 339 0.5× 358 0.6× 151 0.3× 39 1.1k
Jacqueline M. Burrows Australia 26 734 0.5× 344 0.5× 542 0.8× 163 0.3× 1.4k 2.7× 36 2.0k
Andreas Moosmann Germany 24 1.3k 0.9× 302 0.4× 830 1.3× 197 0.3× 1.0k 2.0× 54 2.1k

Countries citing papers authored by Caroline Alfieri

Since Specialization
Citations

This map shows the geographic impact of Caroline Alfieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Alfieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Alfieri more than expected).

Fields of papers citing papers by Caroline Alfieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Alfieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Alfieri. The network helps show where Caroline Alfieri may publish in the future.

Co-authorship network of co-authors of Caroline Alfieri

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Alfieri. A scholar is included among the top collaborators of Caroline Alfieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Alfieri. Caroline Alfieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tanner, Jerome E. & Caroline Alfieri. (2021). The Fatty Acid Lipid Metabolism Nexus in COVID-19. Viruses. 13(1). 90–90. 60 indexed citations
3.
Tanner, Jerome E., et al.. (2011). Inhibition of IκB kinase by thalidomide increases hepatitis C virus RNA replication. Journal of Viral Hepatitis. 19(2). e73–80. 9 indexed citations
5.
Tanner, Jerome E., et al.. (2006). Oligonucleotide-Based Therapeutic Options against Hepatitis C Virus Infection. Antiviral Therapy. 11(3). 273–287. 8 indexed citations
6.
Tanner, Jerome E., et al.. (2005). Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes. Journal of Viral Hepatitis. 13(2). 131–138. 24 indexed citations
7.
Tanner, Jerome E., et al.. (2005). Heat Shock Protein 90 Expression in Epstein-Barr Virus-Infected B Cells Promotes γδ T-Cell Proliferation In Vitro. Journal of Virology. 79(11). 7255–7261. 27 indexed citations
9.
Pedneault, Louise, Normand Lapointe, Caroline Alfieri, et al.. (1998). Natural History of Epstein‐Barr Virus Infection in a Prospective Pediatric Cohort Born to Human Immunodeficiency Virus‐Infected Mothers. The Journal of Infectious Diseases. 177(4). 1087–1090. 5 indexed citations
10.
Tanner, Jerome E., Ming Wei, Caroline Alfieri, et al.. (1997). Antibody and Antibody-Dependent Cellular Cytotoxicity Responses against the BamHI A Rightward Open-Reading Frame-1 Protein of Epstein-Barr Virus (EBV) in EBV-Associated Disorders. The Journal of Infectious Diseases. 175(1). 38–46. 34 indexed citations
11.
Tanner, Jerome E., Francisco Díaz‐Mitoma, Cliona M. Rooney, & Caroline Alfieri. (1997). Anti‐Interleukin‐10 Antibodies in Patients with Chronic Active Epstein‐Barr Virus Infection. The Journal of Infectious Diseases. 176(6). 1454–1461. 20 indexed citations
12.
Pedneault, Louise, Normand Lapointe, Caroline Alfieri, et al.. (1996). Antibody Responses to Two Epstein-Barr Virus (EBV) Nuclear Antigens (EBNA-1 and EBNA-2) During EBV Primary Infection in Children Born to Mothers Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 23(4). 806–808. 6 indexed citations
13.
Cotton, Mark F., et al.. (1994). Acute aqueductal stenosis in a patient with Epstein-Barr virus infectious mononucleosis. The Pediatric Infectious Disease Journal. 13(3). 224–227. 8 indexed citations
14.
Beauparlant, Pierre, et al.. (1994). Radioimmunoprecipitation in the diagnosis of chronic active epstein‐barr virus infection. Journal of Medical Virology. 42(3). 241–246. 1 indexed citations
15.
Alfieri, Caroline, A. C. Allison, & Elliott Kieff. (1994). Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes. Antimicrobial Agents and Chemotherapy. 38(1). 126–129. 29 indexed citations
16.
Alfieri, Caroline, Mark Birkenbach, & Elliott Kieff. (1991). Early events in Epstein-Barr virus infection of human B lymphocytes. Virology. 181(2). 595–608. 239 indexed citations
17.
Jabara, Haifa H., Lynda C. Schneider, Stuart K. Shapira, et al.. (1990). Induction of germ-line and mature C epsilon transcripts in human B cells stimulated with rIL-4 and EBV.. The Journal of Immunology. 145(10). 3468–3473. 68 indexed citations
18.
Beauparlant, Pierre, et al.. (1990). The Diagnosis of Epstein‐Barr Virus‐Associated Polymorphic B Cell Lymphoma in Immunocompromised Patients: Review of Methods. Canadian Journal of Infectious Diseases and Medical Microbiology. 2(3). 109–115. 1 indexed citations
19.
Young, Lawrence S., Caroline Alfieri, Kathleen Hennessy, et al.. (1989). Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative Disease. New England Journal of Medicine. 321(16). 1080–1085. 660 indexed citations breakdown →
20.
Joncas, J. H., Yury Monczak, F Ghibu, et al.. (1989). Brief report: Killer cell defect and persistent immunological abnormalities in two patients with chronic active epstein‐barr virus infection. Journal of Medical Virology. 28(2). 110–117. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026